PLoS ONE (Jan 2019)

Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival.

  • Xavier Catteau,
  • Philippe Simon,
  • Michel Jondet,
  • Michel Vanhaeverbeek,
  • Jean-Christophe Noël

DOI
https://doi.org/10.1371/journal.pone.0210263
Journal volume & issue
Vol. 14, no. 3
p. e0210263

Abstract

Read online

Cancer progression results from a complex interplay between tumor cells and the extracellular milieu. In breast carcinoma, the stromal microenvironment has been suggested to play a major role in promoting tumor growth, progression, and invasion. The stroma of 154 resected specimens of invasive breast carcinoma of no special type was quantified using a digital image analyzer. Statistical analyses were performed between the quantity of stroma and survival, as well as between progression-free survival and clinicopathological data. Levels of myofibroblastic stroma varied from 0-46%, with a median of 15.1% and a standard deviation of 7.5. The myofibroblastic stromal reaction was statistically greater in grade 2 and 3 tumors (p = 0.029). Furthermore, there was a trend for worse progression-free survival in the group of node-negative tumors with strong smooth-muscle actin stromal expression (Log rank = 0.075). The present study demonstrates that the myofibroblastic reaction of breast invasive carcinoma of no special type is not merely a passive reaction, but seems to be an integral part of the neoplastic process by facilitating tumor progression and invasion. Additional, larger studies on mechanisms of stromal change are needed and may potentially lead to novel treatments.